Credit Suisse’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-84,763
| Closed | -$565K | – | 3165 |
|
|
2023
Q3 | $565K | Sell |
84,763
-10,136
| -11% | -$67.6K | ﹤0.01% | 2603 |
|
|
2023
Q2 | $860K | Buy |
94,899
+35,198
| +59% | +$319K | ﹤0.01% | 2478 |
|
|
2023
Q1 | $434K | Buy |
59,701
+6,261
| +12% | +$45.5K | ﹤0.01% | 2804 |
|
|
2022
Q4 | $390K | Buy |
53,440
+24,973
| +88% | +$182K | ﹤0.01% | 2905 |
|
|
2022
Q3 | $220K | Buy |
28,467
+4,338
| +18% | +$33.5K | ﹤0.01% | 3193 |
|
|
2022
Q2 | $164K | Buy |
24,129
+1,001
| +4% | +$6.8K | ﹤0.01% | 3382 |
|
|
2022
Q1 | $184K | Buy |
23,128
+1,507
| +7% | +$12K | ﹤0.01% | 3375 |
|
|
2021
Q4 | $120K | Buy |
+21,621
| New | +$120K | ﹤0.01% | 3515 |
|